In vitro percutaneous absorption of fusidic acid and betamethasone 17-valerate across canine skin

Journal of Small Animal Practice

Volumn 40, Issue 11, 1999, Pages 515-518

  Degim, I T ^a,c   Hadgraft, J ^a   Houghton, E ^b   Teale, P ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Horse Racing Forensic Laboratory   (United Kingdom)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BETAMETHASONE VALERATE; FUSIDIC ACID; GLUCOCORTICOID;

ANIMAL; ARTICLE; DOG; INTRADERMAL DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; SENSITIVITY AND SPECIFICITY; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE 17-VALERATE; CHROMATOGRAPHY, LIQUID; DOGS; FUSIDIC ACID; GLUCOCORTICOIDS; MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY; SKIN ABSORPTION;

EID: 0033218072     PISSN: 00224510     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-5827.1999.tb03010.x     Document Type: Article

References (14)

1. DOLLERY, C. (Ed) (1999) Therapeutic Drugs, 2nd edn. Churchill Livingstone, Edinburgh. pp B38-B41
2. 14C cortisol in man. Journal of Investigative Dermatology 48, 181-183
3. FRANZ, T. J. (1975) Percutaneous absorption. On the relevance of in vitro data. Journal of Investigative Dermatology 64, 190-195
4. HOWES, D., GUY, R . H., HADGRAFT, J., HEYLINGS, J., HOECK, U., KEMPER, F., MAIBACH, H., MARTY, J-P., MERK, H., PARRA, J., REKKAS, D., RONDELLI, I., SCHAEFER, H., TAUBER, U. & VERBIESE, N. (1996) Methods for assessing percutaneous absorption. Alternative to Laboratory Animals 24, 81-106
5. KUBOTA, K., ADEMOLA, J. & MAIBACH, H. I. (1994) Metabolism and degradation of betamethasone 17-valerate in homogenized living skin equivalent. Dermatology 188, 13-17
6. PATERSON, S. (1998) Bacterial skin diseases. In: Skin Diseases of the Dog. Blackwell Science, Edinburgh, pp 19-25
7. SCOTT, D. W., MILLER, W. H. & GRIFFIN, C. E. (1995) Environmental skin diseases. In: Muller and Kirk's Small Animal Dermatology, 5th edn. W. B. Saunders, Philadelphia. pp 883-887
8. SCOTT, R. C. (1990) Absorption through abnormal skin. In: Prediction of Percutaneous Absorption. Eds R. C. Scott, R. H. Guy and J. Hadgraft. London, IBC Technical Services. pp 199-203
9. SKELLY, J. P., SHAH, V. P., MAIBACH, H. I., GUY, R. H., WESTER, R. C, FLYNN, G. & YACOBI, A. (1987) FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies - relevance to bioavailability and bioequivalence. Pharmaceutical Research 4, 265-267
10. STÜTTGEN, G. & BAUER, E. (1988) Penetration and permeation into human skin of fusidic acid in different galenical formulations. Arzneimittel-Forschung/Drug Research 348, 730-735
11. VICKERS, C. F. H. (1969) Percutaneous absorption of sodium fusidate and fusidic acid. British Journal of Dermatology 81, 902-907
12. WESTER, R. C. & MAIBACH, H. I. (1993) Animal models for percutaneous absorption. In: Topical Drug Bioavailability, Bioequivalence and Penetration. Eds V. P. Shah and H. I. Maibach. New York, Plenum Press, pp 333-350
13. WILLIAMS, A. C., CORNWELL, P. A. & BARRY, B. W. (1992) On the non-Gaussian distribution of human skin permeabilities. International Journal of Pharmaceutics 86, 69-77
14. ZENOBLE, R. D. & KEMPPAINEN, R. J. (1987) Adrenocortical suppression by topically applied corticosteroids to healthy dogs. Journal of the American Veterinary Medical Association 191, 685-688